Handelen Assertio Holdings, Inc. - ASRT CFD
Toevoegen aan favorieten- Samenvatting
- Historische gegevens
- Evenementen
- Winst- en verliesrekening
- Balans
- Cash Flow
- Eigendom
Handelsvoorwaarden
| Spread | 0.0452 | ||||||||
|
Overnight-tarief longpositie
Long position overnight fee
Ga naar platform | -0.030779% | ||||||||
|
Overnight-tarief shortpositie
Short position overnight fee
Ga naar platform | -0.013666% | ||||||||
| Tijd van overnight-tarief | 22:00 (UTC) | ||||||||
| Min. verhandelde hoeveelheid | 1 | ||||||||
| Valuta | USD | ||||||||
| Marge | 20% | ||||||||
| Effectenbeurs | United States of America | ||||||||
| Handelscommissie | 0% |
*Information provided by Capital.com
Belangrijkste statistieken
| Prev. Close* | 4.0078 |
| Open* | 4.0676 |
| 1-Jaarlijkse Verandering* | 55.85% |
| Dagelijks bereik* | 4.0177 - 4.2171 |
| 52 wekelijks bereik | 1.86-4.44 |
| Weekgemiddelde volume (10 dagen) | 1.18M |
| Gemiddeld volume (3 maanden) | 20.29M |
| Marktkapitalisatie | 194.62M |
| P/E Ratio | 7.52 |
| Uitstaande Aandelen | 48.29M |
| Omzet | 139.21M |
| EPS | 0.54 |
| Dividend (opbrengst %) | N/A |
| Beta | 1.46 |
| Volgende inkomsten datum | Mar 7, 2023 |
Alle gegevens zijn afkomstig van Refinitiv, behalve de gegevens gemarkeerd met een sterretje, die zijn afkomstig van Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Slotkoers | Change | Change (%) | Openingskoers | High | Low |
|---|---|---|---|---|---|---|
| Feb 2, 2023 | 4.1174 | 0.0698 | 1.72% | 4.0476 | 4.2171 | 3.9978 |
| Feb 1, 2023 | 4.0078 | 0.0402 | 1.01% | 3.9676 | 4.1872 | 3.9676 |
| Jan 31, 2023 | 4.0875 | 0.0897 | 2.24% | 3.9978 | 4.0975 | 3.8782 |
| Jan 30, 2023 | 3.9978 | 0.0199 | 0.50% | 3.9779 | 4.1274 | 3.9081 |
| Jan 27, 2023 | 3.9978 | -0.0498 | -1.23% | 4.0476 | 4.1773 | 3.9679 |
| Jan 26, 2023 | 4.0975 | -0.2193 | -5.08% | 4.3168 | 4.3168 | 4.0676 |
| Jan 25, 2023 | 4.2570 | 0.0897 | 2.15% | 4.1673 | 4.3468 | 4.1673 |
| Jan 24, 2023 | 4.1972 | 0.1496 | 3.70% | 4.0476 | 4.3468 | 3.9878 |
| Jan 23, 2023 | 4.0477 | 0.0200 | 0.50% | 4.0277 | 4.1972 | 3.9978 |
| Jan 20, 2023 | 3.9878 | 0.3890 | 10.81% | 3.5988 | 4.0676 | 3.5988 |
| Jan 19, 2023 | 3.7186 | 0.1894 | 5.37% | 3.5292 | 3.7286 | 3.4794 |
| Jan 18, 2023 | 3.5093 | -0.2791 | -7.37% | 3.7884 | 3.7884 | 3.5093 |
| Jan 17, 2023 | 3.7685 | -0.3888 | -9.35% | 4.1573 | 4.1573 | 3.7685 |
| Jan 13, 2023 | 4.1673 | 0.0000 | 0.00% | 4.1673 | 4.3069 | 4.1474 |
| Jan 12, 2023 | 4.2271 | 0.0897 | 2.17% | 4.1374 | 4.2670 | 4.1174 |
| Jan 11, 2023 | 4.1374 | -0.1196 | -2.81% | 4.2570 | 4.2570 | 4.0676 |
| Jan 10, 2023 | 4.2471 | 0.1895 | 4.67% | 4.0576 | 4.3268 | 4.0576 |
| Jan 9, 2023 | 4.0576 | -0.2792 | -6.44% | 4.3368 | 4.3368 | 4.0576 |
| Jan 6, 2023 | 4.3268 | -0.0100 | -0.23% | 4.3368 | 4.4165 | 4.2371 |
| Jan 5, 2023 | 4.3368 | 0.0997 | 2.35% | 4.2371 | 4.3667 | 4.1573 |
Assertio Holdings, Inc. Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Jaarlijks
- Per kwartaal
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Totale inkomsten | 455.897 | 380.724 | 311.77 | 229.504 | 106.275 | 111.014 |
| Inkomsten | 455.897 | 380.724 | 311.77 | 229.504 | 106.275 | 111.014 |
| Kosten van opbrengsten, totaal | 87.414 | 72.598 | 18.476 | 9.505 | 15.772 | 15.232 |
| Brutowinst | 368.483 | 308.126 | 293.294 | 219.999 | 90.503 | 95.782 |
| Totale bedrijfskosten | 437.165 | 411.778 | 206.111 | 397.547 | 132.637 | 101.59 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 204.498 | 195.696 | 119.218 | 108.866 | 105.323 | 56.555 |
| Onderzoek & Ontwikkeling | 32.631 | 13.718 | 8.042 | 10.106 | 4.213 | 0 |
| Depreciation / Amortization | 106.845 | 102.745 | 101.774 | 101.774 | 24.783 | 28.114 |
| Ongebruikelijke uitgaven (inkomsten) | 5.777 | 27.021 | -41.399 | 167.296 | -17.454 | 1.689 |
| Bedrijfsresultaat | 18.732 | -31.054 | 105.659 | -168.043 | -26.362 | 9.424 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | -83.719 | -73.552 | -68.881 | -58.389 | -15.926 | -10.22 |
| Overige, Netto | 0.485 | 0.681 | 1.197 | 3.948 | -3.225 | 0.243 |
| Netto inkomen voor belastingen | -64.502 | -103.925 | 37.975 | -222.484 | -45.513 | -0.553 |
| Netto inkomen na belastingen | -88.72 | -76.996 | 36.908 | -217.201 | -28.144 | -1.281 |
| Netto inkomen voor extra. Posten | -88.72 | -76.996 | 36.908 | -217.201 | -28.144 | -1.281 |
| Netto inkomen | -88.72 | -102.496 | 36.908 | -217.201 | -28.144 | -1.281 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | -88.72 | -76.996 | 36.908 | -217.201 | -28.144 | -1.281 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | -88.72 | -102.496 | 36.908 | -217.201 | -28.144 | -1.281 |
| Verwateringsaanpassing | 0 | |||||
| Verwaterd Netto Inkomen | -88.72 | -102.496 | 36.908 | -217.201 | -28.144 | -1.281 |
| Verwaterd Gewogen Gemiddelde Aandelen | 15.3242 | 15.6756 | 16.052 | 17.679 | 26.2087 | 43.169 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | -5.78953 | -4.91184 | 2.29928 | -12.2858 | -1.07384 | -0.02967 |
| Verwaterde Genormaliseerde Winst per Aandeel | -5.54449 | -3.23543 | 0.62289 | -6.13488 | -1.50671 | -0.00424 |
| Totale buitengewone posten | -25.5 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Totale inkomsten | 26.839 | 25.373 | 25.472 | 33.328 | 36.538 |
| Inkomsten | 26.839 | 25.373 | 25.472 | 33.328 | 36.538 |
| Kosten van opbrengsten, totaal | 3.766 | 3.621 | 3.05 | 4.896 | 3.795 |
| Brutowinst | 23.073 | 21.752 | 22.422 | 28.432 | 32.743 |
| Totale bedrijfskosten | 19.332 | 37.374 | 19.538 | 25.347 | 24.979 |
| Verkoop/Algemeen/Admin. Uitgaven, Totaal | 7.73 | 26.235 | 9.313 | 13.276 | 10.438 |
| Onderzoek & Ontwikkeling | 0 | 0 | 0 | 0 | |
| Depreciation / Amortization | 6.547 | 7.218 | 7.175 | 7.175 | 8.701 |
| Ongebruikelijke uitgaven (inkomsten) | 1.289 | 0.3 | 0 | 0 | 0.4 |
| Bedrijfsresultaat | 7.507 | -12.001 | 5.934 | 7.981 | 11.559 |
| Renteopbrengsten (-uitgaven), netto Niet-operationeel | -2.684 | -2.605 | -2.495 | -2.437 | -2.327 |
| Overige, Netto | 0.269 | 0.137 | 0.344 | -0.504 | 0.545 |
| Netto inkomen voor belastingen | 5.092 | -14.469 | 3.783 | 5.04 | 9.777 |
| Netto inkomen na belastingen | 4.544 | -14.169 | 3.737 | 4.606 | 9.064 |
| Netto inkomen voor extra. Posten | 4.544 | -14.169 | 3.737 | 4.606 | 9.064 |
| Netto inkomen | 4.544 | -14.169 | 3.737 | 4.606 | 9.064 |
| Inkomsten beschikbaar voor gewone aandelen Excl. Extra. Posten | 4.544 | -14.169 | 3.737 | 4.606 | 9.064 |
| Inkomsten beschikbaar voor gewone aandelen Incl. Extra. Posten | 4.544 | -14.169 | 3.737 | 4.606 | 9.064 |
| Verwaterd Netto Inkomen | 4.544 | -14.169 | 3.737 | 4.606 | 9.064 |
| Verwaterd Gewogen Gemiddelde Aandelen | 38.4795 | 44.706 | 45.055 | 45.026 | 46.127 |
| Verwaterde Winst per Aandeel Exclusief Buitengewone Posten | 0.11809 | -0.31694 | 0.08294 | 0.1023 | 0.1965 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Verwaterde Genormaliseerde Winst per Aandeel | 0.14798 | -0.31258 | 0.08294 | 0.1023 | 0.20454 |
| Rentekosten (inkomsten) - Operationeel nettobedrijfsresultaat | 1.645 |
- Jaarlijks
- Per kwartaal
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Totaal vlottende activa | 306.204 | 230.851 | 208.107 | 103.951 | 94.254 | 103.498 |
| Geldmiddelen en kortetermijnbeleggingen | 177.42 | 128.089 | 110.949 | 42.107 | 20.786 | 36.81 |
| Geldmiddelen & Equivalenten | 117.709 | 126.884 | 110.949 | 42.107 | 20.786 | 36.81 |
| Korte Termijn Investeringen | 59.711 | 1.205 | 0 | |||
| Totale Vorderingen, Netto | 102.589 | 72.482 | 37.211 | 43.544 | 44.35 | 44.361 |
| Accounts Receivable - Trade, Net | 102.056 | 72.482 | 37.211 | 43.257 | 44.35 | 44.361 |
| Total Inventory | 13.033 | 13.042 | 3.396 | 3.412 | 11.712 | 7.489 |
| Prepaid Expenses | 13.162 | 17.238 | 56.551 | 14.888 | 17.406 | 14.838 |
| Total Assets | 1225.34 | 1038.62 | 932.866 | 527.17 | 303.274 | 326.547 |
| Property/Plant/Equipment, Total - Net | 15.526 | 13.024 | 13.064 | 6.273 | 4.784 | 2.262 |
| Property/Plant/Equipment, Total - Gross | 28.606 | 26.945 | 23.837 | 18.143 | 15.57 | 14.011 |
| Accumulated Depreciation, Total | -13.08 | -13.921 | -10.773 | -11.87 | -10.786 | -11.749 |
| Intangibles, Net | 902.149 | 793.873 | 692.099 | 400.535 | 200.082 | 216.054 |
| Other Long Term Assets, Total | 1.458 | 0.869 | 7.812 | 2.247 | 2.575 | 3.154 |
| Total Current Liabilities | 227.242 | 310.58 | 246.036 | 184.553 | 132.686 | 135.019 |
| Accounts Payable | 14.855 | 14.732 | 6.138 | 16.193 | 14.808 | 6.685 |
| Accrued Expenses | 206.858 | 209.544 | 118.765 | 88.36 | 99.161 | 69.339 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 5.529 | 3.804 | 1.133 | 6.775 | 46.821 | |
| Total Liabilities | 974.549 | 869.109 | 712.531 | 469.212 | 247.76 | 224.133 |
| Total Long Term Debt | 718.776 | 544.23 | 446.107 | 271.258 | 72.16 | 61.319 |
| Long Term Debt | 718.776 | 544.23 | 446.107 | 271.258 | 72.16 | 61.319 |
| Other Liabilities, Total | 28.531 | 14.299 | 20.388 | 13.401 | 42.914 | 27.795 |
| Total Equity | 250.788 | 169.508 | 220.335 | 57.958 | 55.514 | 102.414 |
| Preferred Stock - Non Redeemable, Net | 0 | |||||
| Common Stock | 291.634 | 0.006 | 0.006 | 0.008 | 0.013 | 0.004 |
| Additional Paid-In Capital | 75.917 | 389.015 | 402.934 | 457.751 | 483.446 | 531.636 |
| Retained Earnings (Accumulated Deficit) | -116.744 | -219.508 | -182.6 | -399.801 | -427.945 | -429.226 |
| Other Equity, Total | -0.019 | -0.005 | -0.005 | 0 | ||
| Total Liabilities & Shareholders’ Equity | 1225.34 | 1038.62 | 932.866 | 527.17 | 303.274 | 326.547 |
| Total Common Shares Outstanding | 15.4916 | 15.8501 | 16.0463 | 20.222 | 28.3922 | 44.6404 |
| Long Term Investments | 0 | 11.784 | 13.064 | 1.579 | 1.579 | |
| Current Port. of LT Debt/Capital Leases | 82.5 | 120 | 80 | 11.942 | 12.174 | |
| Note Receivable - Long Term | 1.1 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Totaal vlottende activa | 124.069 | 119.348 | 112.545 | 103.498 | 125.115 |
| Geldmiddelen en kortetermijnbeleggingen | 61.033 | 54.428 | 58.726 | 36.81 | 61.389 |
| Geldmiddelen & Equivalenten | 61.033 | 54.428 | 58.726 | 36.81 | 61.389 |
| Totale Vorderingen, Netto | 39.241 | 45.468 | 36.145 | 44.361 | 48.923 |
| Accounts Receivable - Trade, Net | 38.915 | 45.368 | 36.145 | 44.361 | 48.923 |
| Total Inventory | 8.93 | 6.617 | 5.481 | 7.489 | 9.48 |
| Prepaid Expenses | 14.865 | 12.835 | 12.193 | 14.838 | 5.323 |
| Total Assets | 325.424 | 312.016 | 299.305 | 326.547 | 339.135 |
| Property/Plant/Equipment, Total - Net | 2.172 | 2.969 | 2.59 | 2.262 | 1.915 |
| Property/Plant/Equipment, Total - Gross | 13.222 | 14.277 | 14.134 | 14.011 | 13.126 |
| Accumulated Depreciation, Total | -11.05 | -11.308 | -11.544 | -11.749 | -11.211 |
| Intangibles, Net | 193.536 | 186.318 | 179.143 | 216.054 | 207.554 |
| Other Long Term Assets, Total | 5.647 | 1.802 | 3.448 | 3.154 | 2.972 |
| Total Current Liabilities | 109.09 | 116.914 | 100.48 | 135.019 | 138.527 |
| Accounts Payable | 10.609 | 16.483 | 7.666 | 6.685 | 8.523 |
| Accrued Expenses | 76.743 | 72.058 | 64.057 | 69.339 | 72.175 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 12.338 | 12.222 | 12.257 | 12.174 | 12.271 |
| Other Current Liabilities, Total | 9.4 | 16.151 | 16.5 | 46.821 | 45.558 |
| Total Liabilities | 220.121 | 219.751 | 202.445 | 224.133 | 227.273 |
| Total Long Term Debt | 71.834 | 66.751 | 66.41 | 61.319 | 61.25 |
| Long Term Debt | 71.834 | 66.751 | 66.41 | 61.319 | 61.25 |
| Other Liabilities, Total | 39.197 | 36.086 | 35.555 | 27.795 | 27.496 |
| Total Equity | 105.303 | 92.265 | 96.86 | 102.414 | 111.862 |
| Common Stock | 0.018 | 0.004 | 0.004 | 0.004 | 0.004 |
| Additional Paid-In Capital | 528.686 | 529.831 | 530.689 | 531.636 | 532.02 |
| Retained Earnings (Accumulated Deficit) | -423.401 | -437.57 | -433.833 | -429.226 | -420.162 |
| Total Liabilities & Shareholders’ Equity | 325.424 | 312.016 | 299.305 | 326.547 | 339.135 |
| Total Common Shares Outstanding | 43.4359 | 44.494 | 44.6225 | 44.6404 | 45.3354 |
| Long Term Investments | 1.579 | 1.579 | 1.579 | 1.579 |
- Jaarlijks
- Per kwartaal
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Netto-inkomen/Beginsaldo | -88.72 | -102.496 | 36.908 | -217.201 | -28.144 | -1.281 |
| Geldmiddelen uit Operationele Activiteiten | 71.263 | 62.167 | 72.497 | 90.475 | -65.572 | 5.523 |
| Geldmiddelen uit Operationele Activiteiten | 109.375 | 105.502 | 106.426 | 102.946 | 26.431 | 29.077 |
| Deferred Taxes | 23.632 | 0 | 0 | |||
| Niet-Geldelijke Posten | 44.049 | 40.823 | 36.361 | 205.336 | -19.647 | 9.02 |
| Cash Taxes Paid | 14.425 | 0.121 | 6.472 | 4.401 | 1.136 | 0 |
| Contant Betaalde Rente | 71.093 | 55.542 | 48.44 | 37.788 | 17.598 | 10.124 |
| Veranderingen in het Operationeel Kapitaal | -17.073 | 18.338 | -107.198 | -0.606 | -44.212 | -31.293 |
| Geldmiddelen uit Investeringsactiviteiten | 45.536 | 57.894 | -7.082 | -1.481 | 512.801 | -18.525 |
| Kapitaaluitgaven | -2.86 | -0.666 | -5.507 | -1.481 | -0.01 | -0.053 |
| Overige Cash Flow investeringsposten, Totaal | 48.396 | 58.56 | -1.575 | 0 | 512.811 | -18.472 |
| Geldmiddelen uit Financieringsactiviteiten | -100.174 | -110.886 | -81.35 | -157.836 | -468.55 | 29.026 |
| Financiering van Cash Flow Posten | -10.125 | -9.826 | -0.87 | -8.087 | -4.382 | -6.193 |
| Uitgifte (Aflossing) van aandelen, netto | 9.951 | 8.94 | 2.02 | 0.251 | 0.088 | 45.054 |
| Uitgifte (Aflossing) van Schulden, Netto | -100 | -110 | -82.5 | -150 | -464.256 | -9.835 |
| Nettowijziging in Geldmiddelen | 16.625 | 9.175 | -15.935 | -68.842 | -21.321 | 16.024 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 4.544 | -9.625 | -5.887 | -1.281 | 9.064 |
| Cash From Operating Activities | -4.226 | -3.262 | 1.392 | 5.523 | 27.426 |
| Cash From Operating Activities | 6.812 | 14.286 | 21.698 | 29.077 | 8.699 |
| Non-Cash Items | 0.4 | 3.589 | 4.571 | 9.02 | 2.686 |
| Cash Taxes Paid | 0 | 0 | 0 | 0 | -8.36 |
| Cash Interest Paid | 0 | 5.216 | 5.216 | 10.124 | 0 |
| Changes in Working Capital | -15.982 | -11.512 | -18.99 | -31.293 | 6.977 |
| Cash From Investing Activities | 0 | 0 | 0 | -18.525 | -0.404 |
| Capital Expenditures | 0 | 0 | 0 | -0.053 | |
| Cash From Financing Activities | 44.473 | 36.904 | 36.548 | 29.026 | -2.443 |
| Financing Cash Flow Items | -0.388 | -3.4 | -3.421 | -6.193 | -2.443 |
| Issuance (Retirement) of Stock, Net | 44.861 | 45.054 | 45.054 | 45.054 | 0 |
| Issuance (Retirement) of Debt, Net | 0 | -4.75 | -5.085 | -9.835 | |
| Net Change in Cash | 40.247 | 33.642 | 37.94 | 16.024 | 24.579 |
| Other Investing Cash Flow Items, Total | 0 | 0 | -18.472 | -0.404 |
| Naam investeerder | Type investeerder | Percentage uitstaand | Aandelen in bezit | Wijziging aandelen | Datum bezit | Omzetcijfer |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.3717 | 2111276 | 5400 | 2022-09-30 | LOW |
| Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 3.2642 | 1576422 | 696495 | 2022-09-30 | MED |
| Millennium Management LLC | Hedge Fund | 2.1714 | 1048666 | 686009 | 2022-09-30 | HIGH |
| Littlejohn & Co. LLC | Private Equity | 1.9582 | 945677 | 0 | 2022-09-30 | MED |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.8278 | 882707 | -3706 | 2022-09-30 | LOW |
| Marshall Wace LLP | Investment Advisor/Hedge Fund | 1.8105 | 874380 | -52467 | 2022-09-30 | HIGH |
| Bridgeway Capital Management, LLC | Investment Advisor | 1.6478 | 795800 | 606100 | 2022-09-30 | LOW |
| Friess Associates LLC | Investment Advisor | 1.5875 | 766650 | -429802 | 2022-06-30 | HIGH |
| Renaissance Technologies LLC | Hedge Fund | 1.463 | 706535 | 220500 | 2022-09-30 | HIGH |
| First Eagle Investment Management, L.L.C. | Investment Advisor/Hedge Fund | 1.0353 | 499999 | 249946 | 2022-09-30 | LOW |
| D. E. Shaw & Co., L.P. | Hedge Fund | 0.9922 | 479176 | 206598 | 2022-09-30 | MED |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.8627 | 416607 | 12265 | 2022-09-30 | LOW |
| Tekla Capital Management LLC | Investment Advisor | 0.8502 | 410575 | 0 | 2022-09-30 | LOW |
| Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.7761 | 374821 | 374821 | 2022-09-30 | LOW |
| Perritt Capital Management, Inc. | Investment Advisor | 0.7705 | 372100 | 0 | 2022-09-30 | |
| Morgan Stanley & Co. LLC | Research Firm | 0.6532 | 315432 | 179675 | 2022-09-30 | MED |
| GlobeFlex Capital, L.P. | Investment Advisor | 0.6346 | 306448 | 0 | 2022-09-30 | MED |
| Two Sigma Investments, LP | Hedge Fund | 0.6028 | 291114 | 222414 | 2022-09-30 | HIGH |
| Citadel Advisors LLC | Hedge Fund | 0.5852 | 282600 | 199982 | 2022-09-30 | HIGH |
| American Century Investment Management, Inc. | Investment Advisor/Hedge Fund | 0.5563 | 268654 | 182287 | 2022-09-30 | LOW |
Waarom Capital.com? De cijfers spreken voor zichzelf.
Capital.com Group +485000+
Handelaren
65000+
Actieve klanten per maand
$48000000+
Maandelijks beleggingsvolume
$28000000+
Probeer het nu Opgenomen per maand
Handelscalculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Handelscommissie
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Hefboom
20:1
- 20
- 100
- 500
- 1000
- 10000
Investering
Positiegrootte (hefboomwerking x investering):
Openingskoers
Slotkoers
Short Long
Assertio Holdings, Inc. Company profile
Over Assertio Holdings, Inc.
Assertio Holdings, Inc. is een gespecialiseerd farmaceutisch bedrijf dat gedifferentieerde producten aanbiedt aan patiënten door gebruik te maken van een niet-persoonlijk promotiemodel. De voornaamste door de Vennootschap op de markt gebrachte producten zijn INDOCIN (indomethacine) zetpillen, INDOCIN (indomethacine) orale suspensie, CAMBIA (diclofenac kalium voor orale oplossing), Otrexup (methotrexaat) injectie voor subcutaan gebruik, SPRIX (ketorolac tromethamine) neusspray en Zipsor (diclofenac kalium) vloeistof gevulde capsules. De Vennootschap heeft nog andere commercieel beschikbare producten, waaronder OXAYDO (oxycodone HCI, USP) tabletten, uitsluitend voor oraal gebruik. Assertio en Zyla zijn gedeponeerde handelsmerken van de Vennootschap. INDOCIN producten worden gebruikt voor de behandeling van matige tot ernstige reumatoïde artritis, met inbegrip van acute opflakkeringen van de chronische ziekte, matige tot ernstige ankylosing spondylitis, matige tot ernstige osteoartritis, acute pijnlijke schouder (bursitis en/of tendinitis) en acute jicht artritis.
| Industry: | Pharmaceuticals (NEC) |
100 S. Saunders Road
Suite 300
LAKE FOREST
ILLINOIS 60045
US
Winst- en verliesrekening
- Annual
- Quarterly
Mensen bekijken ook
Nog steeds op zoek naar een broker die u kunt vertrouwen?
Sluit u aan bij de 485.000+ handelaren die er wereldwijd voor kozen om met Capital.com te handelen